Altre lingue Achilles Corporation

Azioni

5142

JP3108000005

Mercato chiuso - Japan Exchange Altri mercati azionari 08:00:00 09/07/2024			Variaz. 5gg	Var. 1 gen.
1.613 ^JPY	+0,88%		-0,49%	+4,54%

23/05	Strategic Energy Resources raccoglie 2 milioni di dollari australiani per l'esplorazione di un progetto; le azioni saltano del 50%.	MT
22/05	Achilles Therapeutics collabora con Arcturus Therapeutics per valutare i vaccini antitumorali personalizzati con mRNA	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Tranche Update on Achilles Corporation's Equity Buyback Plan announced on February 27, 2024.	01/07
Strategic Energy Resources Raises AU$2 Million for Project Exploration; Shares Jump 50%	23/05
Achilles Therapeutics Collaborating With Arcturus Therapeutics to Evaluate mRNA Personalized Cancer Vaccines	22/05
Australian Gold and Copper Reports Additional Results at New South Wales Target	16/05
Achilles Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2025	15/05
Achilles Corporation Announces Dividend for the Year Ended March 31, 2024, Payable on June 28, 2024	15/05
Achilles Corporation Provides Consolidated Earning Guidance for the Six Months Ending and Full Year of Fiscal Ending March 31, 2025	15/05
Australian Gold and Copper Hits Gold, Silver Mineralization at New South Wales' Achilles Target; Shares Surge 71%	15/05
ADRs Close Lower; Moatable Inc. Declines 33.3%	04/04
Syncona notes investee Achilles's annual loss narrows	04/04
Tranche Update on Achilles Corporation's Equity Buyback Plan announced on February 27, 2024.	01/04
Achilles Corporation announces an Equity Buyback for 800,000 shares, representing 5.55% for ¥1,600 million.	27/02
Achilles Corporation's Equity Buyback announced on February 24, 2023, has expired.	27/02
Achilles Corporation authorizes a Buyback Plan.	27/02
Ukraine outnumbered, outgunned, ground down by relentless Russia	21/02
Achilles Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	14/02
Achilles Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	14/02
Smith & Nephew Launching Sports Medicine Technologies for Soft Tissue Repair	12/02
Germany's Industry Is Holding Back The Euro, Says SocGen	09/01
Tranche Update on Achilles Corporation's Equity Buyback Plan announced on February 24, 2023.	05/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Achilles Corporation

Azioni

5142

JP3108000005

Altre lingue

Filtri